Lindahl was legal counsel to Senzime AB (publ) in connection with the company’s rights issue
Lindahl was legal counsel to Senzime AB (publ) in connection with the company’s rights issue which was resolved by the board of directors on 23 January 2023 and approved at an extraordinary general meeting on 16 February 2023.
The purpose of the rights issue is to enable the company’s continued growth journey. Through the rights issue, Senzime will receive proceeds of approximately SEK 91.9 million before deduction of transaction costs.
Senzime’s share is listed on Nasdaq Stockholm Main Market and the company develops, manufactures and markets CE- and FDA-cleared patient monitoring systems with the vision of a world without anesthesia- and respiratory-related complications.
Lindahl’s team consisted of Helena Lindbäck, Michaela Larsson, Erika Svensson and Mattias Prage.
Carousel items
-
Cases and transactions
4/3/2025
Lindahl advises Alder in connection with investment in 3Button Group AB
Lindahl has advised Alder in connection with its investment in 3Button Group AB, a leading provider of advanced industrial automation solutions.
-
Knowledge
3/27/2025
Termination Due to Poor Work Performance – How to Act Correctly as an Employer
As an employer, it can be challenging to know how to handle an employee who is not performing as expected and when it is serious enough to justify termination. The so-called LAS reform of 2022, where the term "objective grounds" was replaced with...
-
News articles
3/26/2025
Lindahl ranked in The Legal 500
Lindahl is proud to be ranked in The Legal 500 2025, with outstanding reviews and recognitions both for the firm as a whole and for our individually ranked lawyers.
-
Read more news and insights?